"Quantification of plasma and egg 4,4′ dinitrocarbanilide (DNC) residues for the efficient development of a nicarbazin-based contraceptive for pest waterfowl" (2001 Abstract: Urbanization and associated landscaping has increased the abundance of year-round habitat for waterfowl, resulting in vegetation damage, loss of recreational activities, air transportation mishaps and health hazards. As part of a research program to develop socially acceptable techniques for management of pest bird populations, we are evaluating nicarbazin as a contraceptive in pest and surrogate avian species. As reproductive studies with Canada Geese (Branta canadensis) are tedious due to the dif®culty of conducting controlled ®eld studies and/or breeding geese in captivity, we evaluated the effects of oral nicarbazin administration on the production and hatchability of chicken eggs. Blood plasma and egg DNC concentrations were correlated to contraceptive ef®cacy. Subsequent studies are being conducted with geese to determine the diet nicarbazin concentration required to produce the desired blood and plasma DNC concentrations. This approach permits the expeditious evaluation of formulations and dosing regimes by simply monitoring blood DNC concentrations in target species.
INTRODUCTION
Urban and suburban con¯icts between man and wildlife are increasing in frequency. This is partially attributable to a decrease in wildlife habitat as growing residential areas engulf former wildlife habitat. In addition, landscaping to form parks and corporate campuses has increased the abundance of year-round habitat for waterfowl. This has contributed to increasing year-round urban resident populations of migratory waterfowl species such as mallards (Anas platyrhynchos L) and Canada geese (Branta canadensis L). These populations are frequently associated with vegetation damage, loss of recreational activities and health hazards due to the deposition of large quantities of excreta.
In such situations, population reduction by lethal means is unacceptable to a signi®cant proportion of society. Relocation of pest waterfowl is frequently impracticable as relocation sites are generally unavailable. In an effort to develop socially acceptable techniques to manage pest bird populations, the National Wildlife Research Center (NWRC) is evaluating several compounds as potential contraceptives. One such compound is nicarbazin, an equimolar complex of 4,4'-dintrocarbanilide (DNC) and 4,6-dimethyl-2-pyrimidinol (HDP) (Fig 1) .
Nicarbazin, a US Food and Drug Administration approved anticoccidial agent, has been used in broiler poultry since the mid-1950s. 1 However, when fed to breeder or layer hens, nicarbazin reduces egg hatchability and/or egg production. Adsorption, distribution, metabolism and excretion studies in chicken indicate that DNC is the bioactive component of nicarbazin. While both DNC and HDP are absorbed, 98% of HDP is excreted within 24 h, predominantly via the urine. DNC has a longer half-life, 94% being excreted in 4 days, predominantly via the feces. Tissue and egg residues of DNC are generally 10 to 50 times greater for DNC than for HDP. 2 These data suggest that DNC residues are more applicable than those of HDP for use as a marker of nicarbazin ingestion.
Multiple research studies have shown that the addition of nicarbazin to diets of females resulted in reduced egg production, hatchability, egg weight, shell pigmentation and increased yolk mottling.
1,3±6 Given its long history of safe use as a coccidiostat in chickens, we feel that nicarbazin is a promising contraceptive agent for pest avian wildlife species such as Canada Geese. However, conducting feeding and hatchability studies with wild species such as Canada Geese is tedious, due to the dif®culty of breeding these geese in captivity. To expedite the research process, we have evaluated the effects of multiple dose levels of nicarbazin on the production and hatchability of chicken eggs. Blood and egg concentrations of DNC were also determined. Blood DNC levels were correlated to various levels of contraceptive ef®cacy. Subsequent studies are being conducted with smaller numbers of ducks and geese to determine the nicarbazin dose required to produce equivalent blood DNC levels in target pest species. This should then permit the expeditious evaluation of multiple formulations and dosing regimes by monitoring blood DNC concentrations in relatively small numbers of the target species, ultimately leading to a promising formulation for ®eld testing. Also, estimation of egg DNC concentrations at the target dosing levels will permit us to determine potential non-target hazards resulting from egg predation. This paper summarizes the results of the chicken nicarbazin feeding study.
MATERIALS AND METHODS

In-life experiment
The 35-day in-life portion of this experiment was conducted at the University of Georgia, Poultry Science Department, Athens, GA. Commercial laying chickens were housed in individual cages in a controlled environment with 16 h of light per day. A total of 100 White Leghorn hens at 55 weeks of age were randomly selected for this experiment. The hens were randomly divided into ®ve groups of 20 birds each. As summarized in Fig 2, the in-life portion of the experiment consisted of a 7-day pre-treatment period, a 14-day treatment period, and a 14-day post-treatment period. Egg production and egg weight were recorded daily for all hens. Yolk mottling was also assessed daily by candling. Hens were arti®cially inseminated on day 1 and day 3 of the pre-treatment period, and at weekly intervals thereafter.
During the 7-day pre-treatment period, all hens were fed a commercial layer ration. Eggs laid on days 4±7 were used for obtaining pre-treatment hatchability data. Eggs and blood samples were collected on day 7 of the pre-treatment period and assayed for DNC to determine baseline residue concentrations and/or the presence of chromatographic interferrants. Blood hemolysis was minimized by collecting blood in capillaries containing 1% EDTA. Plasma was prepared by centrifugation. Plasma and eggs were stored at À15°C until analyzed.
During the 14-day treatment period, hens were fed diets containing nominal concentrations of 0, 25, 50, 100 or 150 mg kg À1 nicarbazin. Blood samples and all eggs were collected at 2-day intervals. Two blood samples were collected from each treatment group on each day of 6 sampling days.
2±6 Five blood samples were collected on each day of sampling days 8±14. Two additional eggs were collected from each treatment group on day 13 of the treatment period and day 1 of the post-treatment period. The DNC content was determined in all the blood and two eggs from each sampling day. Percentage hatchability was assessed in the remaining eggs. During the 14-day post-treatment period, the hens were fed nicarbazin-free commercial layer ration. Blood and egg collection continued as during the treatment period.
Hatchability and reproduction rate
Eggs were set four times during the experiment. The ®rst and second sets consisted of eggs collected during the pre-treatment period and during the ®rst 6 days of the treatment period, respectively. The third set consisted of eggs produced from day 7 of the treatment period to day 3 of the post-treatment period. The fourth set consisted of eggs collected from days 4±14 of the post-treatment period. Incubation of eggs was initiated 2±3 days after the last collection day. Hatchability was determined for each treatment group and incubation period as the fraction of set (or incubated) eggs that hatched. Reproduction rate was calculated by multiplying the total number of eggs laid per day by the hatchability. 
Feed preparation and analysis
Nicarbazin-forti®ed feeds were prepared by the University of Georgia Poultry Science Department (Athens, GA) at nominal concentrations of 0, 25, 50, 100 and 150 mg kg
À1
. The nicarbazin content of the feed was subsequently quanti®ed by ultraviolet absorbance (430 nm) following extraction with N,N-dimethylformamide and an alumina column clean-up (AOAC method 956.11).
Blood and egg analyses
High-performance liquid chromatography (HPLC) was used to quantify DNC in blood plasma and eggs. 7, 8 For plasma analysis, plasma (100 ml) was combined with acetonitrile (200 ml), vortex mixed and centrifuged at 16 000 g for 5 min to precipitate proteins. For egg analysis, aliquots of homogenized egg (5 g) were vortex mixed with acetonitrile N,Ndimethylformamide (1 1 by volume; 7 ml). The mixture was sonicated and centrifuged. The supernatant was then removed and ®ltered (45 mm). This procedure was repeated twice more with the addition of acetonitrile dimethylformamide (7 ml) each time. Solvents were combined in a 25-ml volumetric¯ask and brought to volume with acetonitrile dimethylformamide. DNC in the plasma and egg supernatants was quanti®ed by reversed-phase HPLC with UV detection (347 nm).
Statistical analysis
A one-factor ANOVA was conducted with diet = factor, day = covariate and DNC residue concentration = response. Multiple comparisons of least-square means were conducted using the p-diff option in SAS. 9 For each treatment group, reproduction rate (compared with control) and egg and plasma DNC residues were plotted versus day. DNC residues in eggs versus plasma were correlated via linear regression analysis. 10 
RESULTS AND DISCUSSION
The actual concentrations of nicarbazin in the treated diets varied from the nominal concentrations by 2 to 40% (Table 1) . However, the actual nicarbazin concentrations afforded the desired range of concentrations to evaluate the avian contraceptive ef®cacy of nicarbazin-forti®ed feed.
The mean residue data plotted in Fig 3 suggest that egg and plasma DNC residues increased with increasing nicarbazin diet concentrations. As expected, no DNC residues were detected in samples collected from the control group. Also, DNC residues in samples collected from chickens fed 92.5 or 147 g kg À1 nicarbazin forti®ed feed were very similar. These observations were con®rmed by the results of the one-factor ANOVA which indicated that diet effects were highly signi®cant with respect to both egg (F 4,154 = 17.02; P < 0.0001) and plasma (F 4,192 = 40.17; P < 0.0001) DNC residues. Multiple comparisons of least-square means were conducted using the p-diff option in SAS 9 and are summarized in Table 1 . These analyses substantiated the trend of increasing egg and plasma DNC concentrations with increasing nicarbazin diet concentrations. DNC residues in eggs collected from chickens fed 92.5 and 147 mg kg À1 nicarbazin diets were signi®cantly greater than the residues in eggs collected from chickens fed diets containing 34.9 or 0 mg kg À1 nicarbazin. The mean egg DNC residues for the 147 mg kg À1 treatment group were greater than the 54.2 mg kg À1 treatment group. Moreover, the mean egg residues in the 147 versus 92.5 mg kg À1 treatment groups and the 92.5 versus 54.2 mg kg À1 treatment groups were not signi®cantly different. When the plasma DNC concentrations were examined, the mean residues in the 34.9, 54.2, 92.5 and 147 mg kg À1 treatment groups were all signi®cantly greater than the control (0 mg kg À1 ). Mean DNC plasma concentrations were signi®cantly different for each treatment group, except for the 92.5 versus 147 mg kg À1 treatment group. A decrease in production (number of eggs laid) and/or hatchability (eggs hatched/eggs laid) would contribute to decreased reproductive rate. Conversely, an increase in egg production could negate the effects of decreased hatchability on the overall rate of reproduction. For this study, we calculated reproduction rate (relative to control) as an indicator of contraceptive ef®cacy. The data summarized in Fig 4 indicate that decreased reproduction rate associated with nicarbazin treatments was the result of changes in hatchability or changes in egg production and hatchability. For example, in the chickens fed 54.2 or 92.5 mg kg À1 forti®ed feed, the reproduction rate decrease was solely attributed to a decrease in hatchability. The decreased reproduction rate noted in the chickens fed 34.9 or 147 mg kg À1 nicarbazinforti®ed feed resulted from the combined effects of decreased hatchability and decreased reproduction rate. Figure 5 summarizes reproduction rate and mean egg and plasma DNC concentrations with respect to each sampling day of the study for the 0, 54.2 and 147 mg kg À1 treatment groups. Data for the 92.5 mg kg À1 treatment group (not shown) were similar to those for the 54.2 mg kg À1 treatment group. No DNC residues were observed in plasma or eggs collected from the control (0 mg kg À1 ) group. For the nicarbazin-treated groups, the greatest mean plasma DNC concentrations were observed at days 12 or 14, the end of the treatment period. Maximum mean plasma concentrations of 4.1 and 7.8 mg kg À1 were observed for the 54.2 and 147 mg kg À1 treatment groups, respectively. Plasma DNC concentrations rapidly decreased upon withdrawal of the nicarbazin-treated feed. Mean plasma concentrations for all groups reached undetectable levels by day 5 of the posttreatment period.
The trends for plasma and egg residues were similar. For the nicarbazin-treated groups, maximum egg residues were observed several days after plasma residues had maximized. For the ®rst 4 days of the treatment period, plasma residues were greater than egg residues. At day 6 of the treatment period, plasma and egg residues were nearly identical for all groups. Thereafter, mean egg residues exceeded plasma residues for the duration of the treatment period. As the nicarbazin diet concentration increased, egg DNC residues peaked at later times. Maximum egg residues for the 34.9 mg kg À1 group were observed on treatment day 10. Egg residues peaked on treatment day 12 for the 54.2 mg kg À1 group, on day 2 of the posttreatment period for the 92.5 mg kg À1 group and on day 4 of the post-treatment period for the 147 mg kg À1 group. Maximum mean egg DNC concentrations were 4.3, 9.4, 13.9 and 15.3 mg kg À1 for the chickens consuming feed treated with nicarbazin at 34.9, 54.2, 92.5 and 147 mg kg À1 , respectively. Egg DNC resi- dues decreased more slowly than did plasma DNC residues. For the 34.9 mg kg À1 group, egg DNC concentrations did not reach undetectable concentrations until day 10 of the post-treatment period. For the 54.2 and 92.5 mg kg À1 groups, DNC egg residues were detected until day 12 post-treatment. For the 147 mg kg À1 group, low DNC residues (0.6 mg kg À1 ) were detected in eggs harvested 14 days post-treatment.
During days 1±6 of dosing, reproduction was suppressed by approximately 33% in chickens consuming 147 mg kg À1 treated feed. Reduction of reproduction was minimal in the other treatment groups during this time period. For all groups consuming nicarbazin-treated feed, the lowest reproduction rates were observed during the second time period (day 7 of treatment to day 5 post-treatment). For this time period, the reproduction rate of chickens fed 34. during treatment days 6±14. These plasma DNC concentrations represent the target concentrations for evaluating nicarbazin diets in pest avian species such as Canada Geese. While absorption, distribution, metabolism and excretion rates may vary between species, it is likely that nicarbazin treatment resulting in plasma levels ranging from 2 to 6 mg kg À1 for a duration of approximately 1 week will result in a suppression of reproduction by 66±85%.
In a subsequent study, chickens and geese were fed a 125 mg kg À1 nicarbazin-forti®ed diet for 1 week. The maximum DNC blood levels in geese were approximately half of the level observed for chickens. 7 This suggests that, to achieve plasma DNC levels of 6±8 mg kg À1 in geese and hopefully a concurrent 85% decrease in reproduction rate, a diet forti®cation level of approximately 300 mg kg À1 nicarbazin is required. Figure 3 indicates that the plasma and egg residues for each treatment group generally plateaued between treatment day 6 and post-treatment day 2. In Fig 6 , the mean egg residues for each treatment group are plotted versus the corresponding mean plasma residue for this time period. Figure 6 illustrates that the relationship between egg and plasma residues for treatment days 6±14 is linear. 
CONCLUSION
The correlation of blood and egg DNC residues to the contraceptive ef®cacy of nicarbazin treatments provides an approach to facilitate development of a nicarbazin-based contraceptive for pest waterfowl. By monitoring blood DNC levels in pest species, formulations can be evaluated ef®ciently in approximately 2 weeks. In addition, such studies can be conducted throughout the year. This offers a tremendous increase in research ef®ciency over evaluating the contraceptive ef®cacy of formulations under ®eld conditions. Such ®eld studies require large numbers of birds, several months and may only be conducted once a year (during breeding season). Additionally, the quanti®cation of blood and egg DNC residues may also be used to facilitate the ultimate ®eld testing of a promising nicarbazin formulation. Blood samples may be obtained and analyzed to determine the percentage of the pest waterfowl that are in fact consuming the bait and/or how much bait the subjects are consuming. These blood concentrations can also be used to predict the DNC residues in the eggs that will produced during the ®eld study. These egg residues may be important for predicting potential secondary hazards associated with conducting ®eld evaluations of nicarbazin. Moreover, in ®eld studies where obtaining blood from study subjects is undesirable or not possible, egg residues may be used determine the associated plasma residues. These predicted plasma Figure 6 . Mean plasma DNC residues versus mean egg DNC residues for treatment day 6 to post-treatment day 2.
